Jelio, Majkio-Singh, Spasio, Todorovio and 2ivanov-Stakio: Effects of drugs on the assay of serum enzymes 559 J. Clin. Chem. Clin. Biochem. Vol. 22, 1984, pp. 559-563 Effects of Analgesic and Antirheumatic Drugs on the Assay of Seruni Enzymes By Z. Jelic, N. Majkic-Singh, S. Spasic, P. Todorovic and D. Zivanov-Stakic Department of Biochemistry, Faculty of Pharmacy, Beigrade, Yugoslavia (Received November 28, 1983/March 23, 1984) Summary: Interference by some commonly used analgesic and antirheumatic drugs in the spectrophotometric and colorimetric assays of serum enzymes was examined. None'of the investigated methods was significantly influenced by caffeine, phenacetin, ibuprofen or indometacin. Acetylsalicylic acid affected the continuous assays of creatine kinase and lactate dehydrogenase (with pyruvate äs Substrate), and the colorimetric assay of alanine aminotransferase. Aminophenazone interfered with the colorimetric method for the determination of aspartate aminotransferase and alanine aminotransferase, while phenobarbital interfered only with the continuous method for lactate dehydrogenase (with L-lactate äs Substrate). Ketoprofen interfered with the colorimetric assays of lactate dehydrogenase and aspartate aminotransferase, while diclofenac affected the continuous assay of aspartate aminotransferase. None of the tested drugs interfered with the continuous methods for the determinätion of alkaline phosphatase and -hydroxybutyrate dehydrogenase.
Introduction
Drugs may alter clinical laboratory test results either chemically (analytieal interference) or pharmacologically (in vivo effects). Analytieal interference by nine analgesic and antirheumatic drugs in the assays of serum alkaline phosphatase (orthophosphoricmonoester phosphohydrolase, EC 3.1.3.1), lactate dehydrogenase and -hydroxybutyrate dehydrogenase (L-lactäte: NAD* oxidoreductase, EC 1.1.1.27), creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2), aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransfe-J. Clin. Ghem. Clin. Biochem. / Vol. 22,1984 / No. 8 rase, EC 2.6.1.1) and alanine aminotransferase (Lalanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2) was examined.
Diclofenac, indometacin, ibuprofen and ketoprofen are widely used in the management of various rheumatic disorders. The readily available analgesics, acetylsalicylic acid, phenacetin and aminophenazone are also frequently taken without knowledge of the physician. It is thus important to know whether these drugs interfere with clinical laboratory assays. Caffeine and phenobarbital were also tested, being common constituents of various analgesic preparations.
Materials and Methods
To investigate (he effects of drugs on the results of enzyme assays, the general protocol prepared by Siest et al. (1) was followed. Commercial lyophilized human sera were reconstituted with aqueous Solutions of each drug tested. The drug concentrations (tab. 1) were approximately ten times the maximal therapeutic levels (2) (3) (4) (5) . For control sample preparation, the drug Solutions were replaced by distilled water.
For each method, six tests were performed ori control samples, and six on samples containing the drug (Ni = Na = 6); the statistical parameters: mean value (x) and Standard deviation (s), were determined. Using Sludenfs t-test, the significance of the differences between enzyme activities obtained in sera with and without drugs was assessed.
All the assays were performed with a spectürophotometer Pye Unicam SP 8-100. Alkaline phosphatase, lactate dehydrogenase, a-hydroxybutyrate dehydrogenase, creatine kinase, aspartate aminotransferase and alanine aminotransferase activities were determined. The principles and reference data of methods used for the enzyme assays are shown in table2.
Results and Discüssion
No definite influence of indometacin, ibuprofen, caffeine and phenacetin could be detected on any method. The enzyme catalytic activities and their väriä-tions obtained in samples with and without the drugs are shown in table 3, äs well äs the corresponding p values. Day-to-day variations were foürid to be 4.3-8.4% and 8.9-1L2% for continuous and colorimetric methods, respectively (tab. 3).
The apparent catalytic activity of creatine kinase in sera containing acetylsalieylic acid was decreased by 8%, lactate dehydrogenase by 6% (continuoüs method with pyruväte äs Substrate) and alanine aminotransferase by 13% (colorimetric method). Aminophenazone interfered with aspartate aminotransferase and alanine aminotransferase colorimetric assay, yielding 16% lower aspaftate aminotransferase and 22% higher alanine aminotransferase activities. In samples containing phenobartital, 4% higher values for lactate dehydrogenase activity were obtained using L-lactate äs Substrate. Decreased activities of three enzymes were.obtained in the presence of ketoprofeii: lactate dehydrogenase (24%, colorimetric method), aspartate aminotransferase (8%) and alanine aminotransferase (10%) using continuous assays. The continuous test for aspartate aminotransferase catalytic activity determination gave higher results (4%) for samples containing diclofenac. 
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•3 g The effects found were studied further using lower concentrations of drugs, down to the therapeutic levels. The interference of ketoprofen with the colorimetric determination of lactate dehydrogenase catalytic activity could still be seen in the presence of 94 μπιο1/1 (p < 0.001). Significantly decreased activity of aspartate aminotransferase (colorimetric method) was found in samples containing aminophenazone: p < 0.01 with 216 μπιοΐ/ΐ and p < 0.05 with 108 μτηοΐ/ΐ. Figure l shows the dose dependence of these two interferences. Other drugs did not interfere in lower concentrations.
None of the enzyme assays was significantly altered by the drugs in the ranges of theif therapeutic concentrations (tab. 4). The observed effects must therefore be taken into account only in cases of drug overdosage or poisoning. 
